DataMeds AI, Inc. splits its revenue into 3 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Pharmacy Retail Sales at $1.6 million, 89% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Jun 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
|---|---|---|---|---|---|---|---|
| Revenue |
8
|
2
|
2
|
2
|
3
|
8
|
11
|
| Pharmacy Retail Sales |
3
+579.3%
share 42.4%
|
2
+1945.3%
share 89.4%
|
1
+889.2%
share 72.7%
|
1
share 30.0%
|
0
share 5.7%
|
0
share 1.0%
|
0
share 1.1%
|
| Third Party Logistics Services |
1
share 8.5%
|
0
-25.4%
share 6.9%
|
0
+147.9%
share 12.8%
|
0
share 9.3%
|
0
share 6.7%
|
0
share 2.1%
|
0
share 0.7%
|
| Product |
4
share 49.2%
|
0
-99.1%
share 3.8%
|
0
-97.9%
share 14.5%
|
1
share 60.7%
|
3
share 87.5%
|
8
share 96.9%
|
11
share 98.2%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
- Listed as
- MEDS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Tampa, FL
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2030763
- Former names
- Wellgistics Health, Inc. (until Jul 21, 2026); Danam Health, Inc (until Sep 27, 2024)
Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
- Mckesson Corp MCK
- Cencora, Inc. COR
- Cardinal Health Inc CAH
- Herbalife Ltd. HLF
- Nu Skin Enterprises, Inc. NUS
- EnerSyn Global Inc. ESYN
- Cosmos Health Inc. COSM
- Cellyan Biotechnology Co., Ltd HKPD
All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.